HPV vaccine nears zero death risk

A recent study has revealed that receiving the human papillomavirus (HPV) vaccine at an early age significantly reduces the risk of death from cervical cancer before the age of thirty. Mortality rates have declined noticeably since the vaccine's introduction in 2008, with no reported deaths among young women between 2020 and 2024 in England. The researchers pointed out that the vaccine has saved hundreds of lives and is expected to prevent thousands of deaths in the future, as part of efforts to eliminate cervical cancer by 2040.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل